America will be the first country to roll out a covid-19 vaccine
Editor’s note: Some of our covid-19 coverage is free for readers of The Economist Today, our daily newsletter. For more stories and our pandemic tracker, see our hub
ASKED WHAT keeps her up at night as Texas prepares for the arrival of the first covid-19 vaccines, Imelda Garcia from the state’s health department singles out two opposite scenarios: either a serious shortage of vaccine, or lots of it sitting around unused because nobody wants to take it. These two worries are on the minds of many other public-health experts as 6.4m doses of vaccine stand ready to be dispatched across America, on a nod by the Food and Drug Administration (FDA), the federal drug regulator.
That nod is expected on December 10th or shortly after, when the FDA will make a decision on the first covid-19 vaccine submitted for approval in America, a jab developed by the drug firms Pfizer and BioNTech. Moderna, the developer of another vaccine, is expected to undergo FDA review on December 17th. Both vaccines are about 95% effective if administered in a two-dose regimen. They are unlikely to stem America’s runaway epidemic until next spring, at best. But America is leading the way on...